Monopar Therapeutics
Price & Volume
Stats
See moreOpen | $70.82 |
Previous Close | $70.50 |
Day Range | $70.07-$72.19 |
52W Range | $21-$105 |
Market Cap | $471.1M |
Shares Short | 507,439 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.96 |
News
See moreYahoo Finance • last month
Monopar Therapeutics GAAP EPS of -$0.48 misses by $0.05
Yahoo Finance • last month
Coinbase upgraded, Six Flags downgraded: Wall Street's top analyst calls
Yahoo Finance • last month
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
Yahoo Finance • 2 months ago
How the Narrative Around AstraZeneca Is Shifting Amid New Risks and Pipeline Developments
About
CEO | Dr. Chandler D. Robinson M.B.A., M.D., M.Sc. |
CFO | Mr. Quan Anh Vu |
Address | 1000 Skokie Boulevard, Wilmette, IL, United States, 60091 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
